Log In
Print
BCIQ
Print
Print this Print this
 

FT1050

  Manage Alerts
Collapse Summary General Information
Company Fate Therapeutics Inc.
DescriptionSmall molecule prostaglandin E2 analog
Molecular Target Prostaglandin E2 (PGE2) receptor
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationHematology
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today